Selectis Health annual debt-to-ebitda ratio
2012
2013
2016
2017
2018
2019
2020
2021
2022
Selectis Health Debt-to-EBITDA Ratio Growth & History (GBCS)
Selectis Health's debt-to-ebitda ratio was 25.50 for fiscal 2022.
View full Selectis Health company overviewSelectis Health annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | 25.50 | −13.84 | −35.19% |
| 2021 | 2021-12-31 | 39.34 | 31.33 | +390.93% |
| 2020 | 2020-12-31 | 8.01 | −6.49 | −44.75% |
| 2019 | 2019-12-31 | 14.50 | −8.71 | −37.52% |
| 2018 | 2018-12-31 | 23.21 | 2.13 | +10.12% |
| 2017 | 2017-12-31 | 21.08 | −2.12 | −9.13% |
| 2016 | 2016-12-31 | 23.20 | — | — |
| 2013 · Jun 30 | 2013-06-30 | 2.03 | 0.33 | +19.77% |
| 2012 | 2012-06-30 | 1.69 | — | — |
Selectis Health quarterly debt-to-ebitda ratio
Q4.12
Q1.13
Q4.11
Q1.12
Q4.13
Q1.14
Q1.15
Q2.15
Q3.15
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.25
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | 168.86 | — | — |
| Q4 2022 | 2022-12-31 | 25.50 | −13.84 | −35.19% |
| Q3 2022 | 2022-09-30 | 17.05 | 0.18 | +1.04% |
| Q2 2022 | 2022-06-30 | 11.81 | −3.45 | −22.60% |
| Q1 2022 | 2022-03-31 | 20.00 | 10.79 | +117.14% |
| Q4 2021 | 2021-12-31 | 39.34 | 31.33 | +390.93% |
| Q3 2021 | 2021-09-30 | 16.88 | 8.08 | +91.94% |
| Q2 2021 | 2021-06-30 | 15.26 | 5.60 | +58.03% |
| Q1 2021 | 2021-03-31 | 9.21 | −4.60 | −33.31% |
| Q4 2020 | 2020-12-31 | 8.01 | −6.49 | −44.75% |
| Q3 2020 | 2020-09-30 | 8.79 | −6.54 | −42.66% |
| Q2 2020 | 2020-06-30 | 9.65 | −9.28 | −49.02% |
| Q1 2020 | 2020-03-31 | 13.81 | −7.46 | −35.06% |
| Q4 2019 | 2019-12-31 | 14.50 | −8.71 | −37.52% |
| Q3 2019 | 2019-09-30 | 15.33 | −1.65 | −9.72% |
| Q2 2019 | 2019-06-30 | 18.94 | 1.29 | +7.29% |
| Q1 2019 | 2019-03-31 | 21.27 | 4.10 | +23.90% |
| Q4 2018 | 2018-12-31 | 23.21 | 2.13 | +10.12% |
| Q3 2018 | 2018-09-30 | 16.99 | −16.78 | −49.70% |
| Q2 2018 | 2018-06-30 | 17.65 | −31.79 | −64.30% |
| Q1 2018 | 2018-03-31 | 17.16 | −5.27 | −23.50% |
| Q4 2017 | 2017-12-31 | 21.08 | −2.12 | −9.13% |
| Q3 2017 | 2017-09-30 | 33.77 | — | — |
| Q2 2017 | 2017-06-30 | 49.44 | — | — |
| Q1 2017 | 2017-03-31 | 22.44 | — | — |
| Q4 2016 | 2016-12-31 | 23.20 | — | — |
| Q3 2015 | 2015-09-30 | 17.96 | — | — |
| Q2 2015 | 2015-06-30 | 19.61 | — | — |
| Q1 2015 | 2015-03-31 | 34.21 | — | — |
| Q1 2014 · Sep 30 | 2013-09-30 | 2.23 | 0.97 | +76.79% |
| Q4 2013 · Jun 30 | 2013-06-30 | 7.39 | 5.70 | +337.03% |
| Q1 2012 · Mar 31 | 2013-03-31 | 0.66 | — | — |
| Q4 2011 · Dec 31 | 2012-12-31 | 0.71 | — | — |
| Q1 2013 | 2012-09-30 | 1.26 | — | — |
| Q4 2012 | 2012-06-30 | 1.69 | — | — |
Selectis Health debt-to-ebitda ratio trends
Over the last five fiscal years, Selectis Health's debt-to-ebitda ratio increased from 21.08 to 25.50, a change of 4.41. The latest reported quarter, Q3 2025, shows 168.86.
About the metric
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
Calculation and source
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Selectis Health source filings ↗